AAAAAA

   
Results: 1-22 |
Results: 22
Progressive arterial thrombosis in a patient with non-Hodgkin's lymphoma, a lupus anticoagulant, factor V Leiden mutation and paraprotein, following chemotherapy
Authors: Shaw, BE Perry, D Hoffbrand, AV
Citation: Be. Shaw et al., Progressive arterial thrombosis in a patient with non-Hodgkin's lymphoma, a lupus anticoagulant, factor V Leiden mutation and paraprotein, following chemotherapy, LEUK LYMPH, 42(1-2), 2001, pp. 221-223
Heterogeneity of VH-JH gene rearrangement patterns: an insight into the biology of B cell precursor ALL
Authors: Moreira, I Papaioannou, M Mortuza, FY Gameiro, P Palmisano, GL Harrison, CJ Prentice, HG Mehta, AB Hoffbrand, AV Foroni, L
Citation: I. Moreira et al., Heterogeneity of VH-JH gene rearrangement patterns: an insight into the biology of B cell precursor ALL, LEUKEMIA, 15(10), 2001, pp. 1527-1536
The PML-RAR alpha transcript in long-term follow-up of acute promyelocyticleukemia patients
Authors: Gameiro, P Vieira, S Carrara, P Silva, AL Diamond, J de Sousa, AB Mehta, AB Prentice, HG Guimaraes, JE Hoffbrand, AV Foroni, L Parreira, A
Citation: P. Gameiro et al., The PML-RAR alpha transcript in long-term follow-up of acute promyelocyticleukemia patients, HAEMATOLOG, 86(6), 2001, pp. 577-585
Diagnosing myocardial iron overload
Authors: Hoffbrand, AV
Citation: Av. Hoffbrand, Diagnosing myocardial iron overload, EUR HEART J, 22(23), 2001, pp. 2140-2141
Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells
Authors: Wickremasinghe, RG Ganeshaguru, K Jones, DT Lindsay, C Spanswick, VJ Hartley, JA Wadhwa, M Thorpe, R Hoffbrand, AV Prentice, HG Mehta, AB
Citation: Rg. Wickremasinghe et al., Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells, BR J HAEM, 114(3), 2001, pp. 608-615
The history of folic acid
Authors: Hoffbrand, AV Weir, DG
Citation: Av. Hoffbrand et Dg. Weir, The history of folic acid, BR J HAEM, 113(3), 2001, pp. 579-589
Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediatekilling of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation
Authors: Jones, DT Ganeshaguru, K Virchis, AE Folarin, NI Lowdell, MW Mehta, AB Prentice, HG Hoffbrand, AV Wickremasinghe, RG
Citation: Dt. Jones et al., Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediatekilling of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation, BLOOD, 98(9), 2001, pp. 2800-2807
Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblasticleukemia reveals preferential usage of J(H)-proximal variable gene segments
Authors: Mortuza, FY Moreira, IM Papaioannou, M Gameiro, P Coyle, LA Gricks, CS Amlot, P Prentice, HG Madrigal, A Hoffbrand, AV Foroni, L
Citation: Fy. Mortuza et al., Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblasticleukemia reveals preferential usage of J(H)-proximal variable gene segments, BLOOD, 97(9), 2001, pp. 2716-2726
Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value
Authors: Codrington, R O'Connor, HE Jalali, GR Carrara, P Papaioannou, M Hart, SM Hoffbrand, AV Potter, M Prentice, HG Harrison, CJ Foroni, L
Citation: R. Codrington et al., Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value, BR J HAEM, 111(4), 2000, pp. 1071-1079
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major
Authors: Telfer, PT Prestcott, E Holden, S Walker, M Hoffbrand, AV Wonke, B
Citation: Pt. Telfer et al., Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major, BR J HAEM, 110(4), 2000, pp. 971-977
The United Kingdom Childhood Cancer Study: objectives, materials and methods
Authors: Boulton, A Boyd, P Cheng, KK Cook, J Gilman, EA Lunt, D Mahler, H Walker, C Wardroper, M Darbyshire, PJ Hill, FGH Mann, JR Morland, B Raafat, F Stevens, MCG Ahmed, A Amos, P Bone, V Bonney, S Bray, M Cambouropoulos, P Cook, S Day, N Elkins, S Hensel, F Lucas, P Pettinger, J Pugsley, M Ruja, E Skinner, J Williams, D Braodbent, V Williams, M Alcock, M Bell, K Buchan, M Cartwright, R Cusack, H Fear, N Griffiths, S Jarvis, J Johnson, P Kane, E Law, G Moorman, A Prajapati, J Roberts, P Roman, E Simpson, J Sinclair, V Staines, A Thackrah, C Thistlethwaite, S Waller, B Bailey, C Kinsey, S Lewis, I Picton, S Squire, R Taylor, R Beck, JM Doran, RML Livingston, JH Van Hille, P Beddis, I Cameron, MM Craft, A Hale, J Kernahan, J Reid, M Windebank, K Pearson, A Skinner, R Marks, S Achilles, J Alam, S Birch, JM Blair, V Buckley, B Clarkson, M Eden, OB Howell, S Kellaway, C Lashford, L Leeke, S Leggett, P Murphy, AV O'Rorke, C Panton, S Paxon, J Pots, H Roberts, C Rothwell, J Stephenson, W Whelpton, B Caswell, M McDowell, H Pizer, BL Gattamaneri, R Brock, J Kelsey, AM Stevens, R Will, A Brennan, B Brydon, J Dodds, C Findlay, E Finucane, J Fraser, J Harkness, E Heary, A Hunter, N Juszczak, E Lang, M Lapsley, E McArthur, A MacCalman, A McKinney, PA Proudfoot, K Smith, C Smith, K Stockton, D Thomson, CS Vickers, R Wilkie, R King, D Mackinlay, G Shaw, P Thomas, A Wallace, H Carachi, R Gibson, BS Simpson, E Cruickshank, G Hide, TAH Gregor, A Steers, AJW Barrett, A Hamblen, DL Kaye, SB Mackie, R Allen, A Jones, AA Beeby, S Bignall, V Breeze, L Deacon, J MacDonald, M Matthews, F Meggitt, C Peto, J Sharpe, E Spencer, C Swales, J Thorne, M Trowbridge, P Webster-King, J Williams, E Bell, BA Johnston, FG Marsh, HT Uttley, D Bartlett, J Evans, A Gullan, RW Glaser, MG Peterson, D Southcott, BM Cavanagh, N Pearl, K Scott, D Darby, CW Chessels, J Evans, J Gaze, M Hann, IM Harkness, W Hayward, R Michalski, A Passmore, J Phillips, M Pritchard, J Clark, KGA MacDonald, EA Neville, BGR Robb, SA Robinson, RO Hardwidge, C Padgham, N Lobo, VJ Keen, C Hindmarsh, PC Kilby, AM Souhami, RL Tuft, S Thomas, RM Ward, P Scott, M Hoffbrand, AV Prentice, HG Gutteridge, CG Newland, AC Brada, M Henk, JM Meller, S Pinkerton, R Jones, KP Cannon, S Murrell, DS Hungerford, JL Kingston, JE Plowman, PN Young, B Ball, SE Capps, SNJ Davies, EG Holmes, SJK Carr, R Mercer, DM Smith, MA Andrews, VE Hughes, RG Ansell, P Baker, K Beral, V Black, J Boon, S Burge, C Burge, F Cliff, A Deciaccio, D Dorman, P Heydon, F Langley, N Pelerin, M Roemmele, J Sayers, K Townshend, P Harman, S Loftus, J Roth, S Lee, B Buchdahl, R Dunger, DB Mitchell, C Moncrieff, MKM Tam, PKH Wheeler, K Reiser, J Joss, V Moir, DJ Darmady, J Daish, P Liberman, MM Al-Izzi, MS Adams, CBT Kerr, RSC Teddy, PJ Barton, CJ Newman, CL Gabriel, CM O'Hea, M Sherrin, S Watson, A Douek, E Connell, JA Kelly, S Beswick, A Eldridge, B Elwood, P Hughes, J Phillips, M Webb, D Alexander, FE Bennett-Lloyd, B Davis, A Dunn, R Little, J Longdon, S Mitchell, M Muir, S Sturitis, J Kennedy, C Kohler, J Lang, D Radford, M Foreman, N Foot, A Mott, M Noblett, H Oakhill, A Sandeman, D Baumer, J Ward, P McNinch, A Gilbertson, N Bosley, A Richardson, S Challacombe, D French, T Bate, L Chilvers, CED Faulkner, G Hawtin, P Jenkinson, C Kelham, P Mackie, I Mackie, M Muir, KR O'Dwyer, J Williams, A Nelson, C Howarth, C Madi, M Shannon, R Forman, K Hewitt, M Punt, J Walker, D Gerrard, M Lilleyman, JS Vora, A Draper, G Harrison, C Doll, R Richards, S Ayres, M Carter, R Dearden, SP Hussain, A Kennedy, J Ravetto, P Ruprai, A Taylor, GM Taylor, J Watson, PD Colman, SM Greaves, MF Price, CM Goodhead, DT Allen, S Bartlett, D Blackwell, RP Fry, F Maslanyj, M Mee, T Miles, J Adams, G
Citation: A. Boulton et al., The United Kingdom Childhood Cancer Study: objectives, materials and methods, BR J CANC, 82(5), 2000, pp. 1073-1102
Ceramide-induced killing of normal and malignant human lymphocytes is by anon-apoptotic mechanism
Authors: Mengubas, K Riordan, FA Bravery, CA Lewin, J Owens, DL Mehta, AB Hoffbrand, AV Wickremasinghe, RG
Citation: K. Mengubas et al., Ceramide-induced killing of normal and malignant human lymphocytes is by anon-apoptotic mechanism, ONCOGENE, 18(15), 1999, pp. 2499-2506
Achievements in hematology in the twentieth century: An introduction
Authors: Hoffbrand, AV Fantini, B
Citation: Av. Hoffbrand et B. Fantini, Achievements in hematology in the twentieth century: An introduction, SEM HEMATOL, 36(4), 1999, pp. 1-4
Nutritional anemias
Authors: Hoffbrand, AV Herbert, V
Citation: Av. Hoffbrand et V. Herbert, Nutritional anemias, SEM HEMATOL, 36(4), 1999, pp. 13-23
Killing of T lymphocytes by synthetic ceramide is by a nonapoptotic mechanism and is abrogated following mitogenic activation
Authors: Mengubas, K Fahey, AA Lewin, J Mehta, AB Hoffbrand, AV Wickremasinghe, RG
Citation: K. Mengubas et al., Killing of T lymphocytes by synthetic ceramide is by a nonapoptotic mechanism and is abrogated following mitogenic activation, EXP CELL RE, 249(1), 1999, pp. 116-122
Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis
Authors: Foroni, L Harrison, CJ Hoffbrand, AV Potter, MN
Citation: L. Foroni et al., Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis, BR J HAEM, 105(1), 1999, pp. 7-24
Biochemical and genetic control of apoptosis: Relevance to normal hematopoiesis and hematological malignancies
Authors: Wickremasinghe, RG Hoffbrand, AV
Citation: Rg. Wickremasinghe et Av. Hoffbrand, Biochemical and genetic control of apoptosis: Relevance to normal hematopoiesis and hematological malignancies, BLOOD, 93(11), 1999, pp. 3587-3600
Genetic and acquired predisposing factors and treatment of osteoporosis inthalassaemia major
Authors: Wonke, B Jensen, C Hanslip, JJ Prescott, E Lalloz, M Layton, M Erten, S Tuck, S Agnew, JE Raja, K Davies, K Hoffbrand, AV
Citation: B. Wonke et al., Genetic and acquired predisposing factors and treatment of osteoporosis inthalassaemia major, J PED END M, 11, 1998, pp. 795-801
High incidence of osteoporosis in thalassaemia major
Authors: Jensen, CE Tuck, SM Agnew, JE Koneru, S Morris, RW Yardumian, A Prescott, E Hoffbrand, AV Wonke, B
Citation: Ce. Jensen et al., High incidence of osteoporosis in thalassaemia major, J PED END M, 11, 1998, pp. 975-977
FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission
Authors: Deane, M Koh, M Foroni, L Galactowicz, G Hoffbrand, AV Lawler, M Secker-Walker, L Prentice, HG
Citation: M. Deane et al., FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission, BONE MAR TR, 22(12), 1998, pp. 1137-1143
Iron chelation with oral deferiprone in patients with thalassemia
Authors: Wonke, B Telfer, P Hoffbrand, AV
Citation: B. Wonke et al., Iron chelation with oral deferiprone in patients with thalassemia, N ENG J MED, 339(23), 1998, pp. 1712-1712
High prevalence of low bone mass in thalassaemia major
Authors: Jensen, CE Tuck, SM Agnew, JE Koneru, S Morris, RW Yardumian, Y Prescott, E Hoffbrand, AV Wonke, B
Citation: Ce. Jensen et al., High prevalence of low bone mass in thalassaemia major, BR J HAEM, 103(4), 1998, pp. 911-915
Risultati: 1-22 |